Literature DB >> 3708973

Eight- to 13-year follow-up evaluation of chemonucleolysis patients.

E J Nordby.   

Abstract

739 patients treated eight to 13 years previously with chymopapain injection are evaluated by questionnaire. The results were 76% satisfactory and 24% unsatisfactory. When those with prior surgery, midline discs, and spondylolisthesis were eliminated, there is a satisfactory result in 82% with 60% excellent, reinforcing the importance of patient selection for the procedure. Thirty-one percent of patients had preoperative myelograms, and all had discograms and were done under general anesthesia with the single needle technique. Of the excellent and good results, 50% had a two-level injection, while one-level injections produced only 23% and 20%, respectively. Results in midline discs are comparable to lateral displacement and the 13 patients with spondylolisthesis had 85% satisfactory outcome. In ten patients younger than 19 years of age, only one was a failure. Sixteen percent of patients had prior surgery and they reported a successful outcome of injection in 55%. Of the 179 unsatisfactory results in the series, subsequent treatment reduced the rate of failed end results to 14%. The study verifies the persistence of early satisfactory results and shows no late complications such as symptomatic iatrogenic spinal stenosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708973

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  The results of "lumbar disc surgery" following unsuccessful chemonucleolysis.

Authors:  M Brock; L Pedretti; H M Mayer
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

2.  Chemonucleolysis: correlation of results with the size of the herniation and the dimensions of the spinal canal.

Authors:  C Garreau; I Dessarts; B Lassale; G Morvan; A Deburge; M Benoist
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.